Stable Production of Lentiviral Vectors
    1.
    发明申请
    Stable Production of Lentiviral Vectors 有权
    慢病毒载体的稳定生产

    公开(公告)号:US20140051125A1

    公开(公告)日:2014-02-20

    申请号:US13819991

    申请日:2011-09-01

    IPC分类号: C12N15/86

    摘要: The present invention provides new stable packaging cell lines and producer cell lines as well as methods to obtain them, and a new method to produce lentiviral vectors using such cell lines. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITR, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a first intermediate including only the structural and regulatory HIV proteins gag/pol and rev, to be used as starting point to obtain stable packaging cell lines as well as producer cell lines.

    摘要翻译: 本发明提供新的稳定的包装细胞系和生产细胞系以及获得它们的方法,以及使用这种细胞系产生慢病毒载体的新方法。 本发明的新方法和包装细胞系使用杆状AAV杂交系统产生,用于结构和调节性慢病毒蛋白的稳定表达,该系统包含含有侧翼为AAV ITR的整合盒的杆状病毒主链,与编码rep 蛋白。 该系统允许获得结构和调节的HIV-1蛋白gag / pol和rev的稳定整合。 该系统允许获得仅包括结构和调节性HIV蛋白gag / pol和rev的第一个中间体,用作起始点以获得稳定的包装细胞系以及生产细胞系。

    Semi-stable production of lentiviral vectors
    3.
    发明授权
    Semi-stable production of lentiviral vectors 有权
    半稳定生产慢病毒载体

    公开(公告)号:US09133481B2

    公开(公告)日:2015-09-15

    申请号:US13819989

    申请日:2011-09-01

    摘要: The present invention provides a new semi-stable packaging cell line and a method to produce lentiviral vectors (LV), using the semi-stable packaging cell line. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITRs, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a cell line including the structural and regulatory HIV proteins gag/pol and rev, to be used for a semi-stable LV production.

    摘要翻译: 本发明提供一种新的半稳定包装细胞系和使用半稳定包装细胞系产生慢病毒载体(LV)的方法。 本发明的新方法和包装细胞系使用杆状AAV杂交系统产生,用于稳定表达结构和调节性慢病毒蛋白,该系统包含含有侧翼为AAV ITR的整合盒的杆状病毒主链,与编码rep 蛋白。 该系统允许获得结构和调节的HIV-1蛋白gag / pol和rev的稳定整合。 该系统允许获得包括用于半稳定LV生产的结构和调节性HIV蛋白gag / pol和rev的细胞系。

    Semi-Stable Production of Lentiviral Vectors
    4.
    发明申请
    Semi-Stable Production of Lentiviral Vectors 有权
    慢病毒载体的半稳定生产

    公开(公告)号:US20130164840A1

    公开(公告)日:2013-06-27

    申请号:US13819989

    申请日:2011-09-01

    IPC分类号: C12N15/867

    摘要: The present invention provides a new semi-stable packaging cell line and a method to produce lentiviral vectors (LV), using the semi-stable packaging cell line. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITRs, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a cell line including the structural and regulatory HIV proteins gag/pol and rev, to be used for a semi-stable LV production.

    摘要翻译: 本发明提供一种新的半稳定包装细胞系和使用半稳定包装细胞系产生慢病毒载体(LV)的方法。 本发明的新方法和包装细胞系使用杆状AAV杂交系统产生,用于稳定表达结构和调节性慢病毒蛋白,该系统包含含有侧翼为AAV ITR的整合盒的杆状病毒主链,与编码rep 蛋白。 该系统允许获得结构和调节的HIV-1蛋白gag / pol和rev的稳定整合。 该系统允许获得包括用于半稳定LV生产的结构和调节性HIV蛋白gag / pol和rev的细胞系。

    Hiv Vif Mutants
    5.
    发明申请
    Hiv Vif Mutants 有权
    Hiv Vif突变体

    公开(公告)号:US20080286248A1

    公开(公告)日:2008-11-20

    申请号:US11815490

    申请日:2006-03-07

    申请人: Chiara Bovolenta

    发明人: Chiara Bovolenta

    摘要: A polynucleotide comprising a nucleotide sequence encoding Vif, wherein each of the amino acids corresponding to positions 127, 128, 130, 131, 132 and 142 of the amino acid sequence in FIG. 1A representing the Vif wild-type consensus sequence, are replaced with another amino acid, and wherein the nucleotide sequence does not encode the amino acid sequence shown in FIG. 2, representing the Vif sequence of the F12 non-producer variant of HIV-1.

    摘要翻译: 包含编码Vif的核苷酸序列的多核苷酸,其中对应于图1中氨基酸序列的位置127,128,130,131,132和142的每个氨基酸。 代表Vif野生型共有序列的1A被另一个氨基酸取代,并且其中所述核苷酸序列不编码图1所示的氨基酸序列。 2,代表HIV-1的F12非生产性变体的Vif序列。

    HIV vif mutants
    6.
    发明授权
    HIV vif mutants 有权
    HIV vif突变体

    公开(公告)号:US08912152B2

    公开(公告)日:2014-12-16

    申请号:US11815490

    申请日:2006-03-07

    申请人: Chiara Bovolenta

    发明人: Chiara Bovolenta

    摘要: A polynucleotide comprising a nucleotide sequence encoding Vif, wherein each of the amino acids corresponding to positions 127, 128, 130, 131, 132 and 142 of the amino acid sequence in FIG. 1A representing the Vif wild-type consensus sequence, are replaced with another amino acid, and wherein the nucleotide sequence does not encode the amino acid sequence shown in FIG. 2, representing the Vif sequence of the F12 non-producer variant of HIV-1.

    摘要翻译: 包含编码Vif的核苷酸序列的多核苷酸,其中对应于图1中氨基酸序列的位置127,128,130,131,132和142的每个氨基酸。 代表Vif野生型共有序列的1A被另一氨基酸取代,并且其中所述核苷酸序列不编码图1所示的氨基酸序列。 2,代表HIV-1的F12非生产性变体的Vif序列。